Alpha-GPC (L-Alpha glycerylphosphorylcholine / Choline alfoscerate) for Stroke Recovery
Alpha-GPC is not a proven treatment for stroke recovery: the case for benefit rests on dated, low-quality trials, while a very large 2021 cohort links long-term use to higher future stroke risk. The mixed picture and that safety signal mean it should be approached with genuine caution.
Why this grade7-layer evidence engine
The grade is C (weak evidence) because the human data pointing to benefit are thin and aging. The strongest positive piece is the 1994 Italian multicenter trial (PMID 8030842, n=2044), which reported meaningful gains in neurological and cognitive scores after stroke but was open-label and single-arm with no placebo control, so it carries a high risk of bias. A 2023 systematic review and meta-analysis (PMID 37109211, n=8357, moderate quality) concluded choline alphoscerate improved neurological function and reduced dependency after stroke, but it pooled mostly older, methodologically weak studies.
The decisive caveat is safety. A 2021 South Korean cohort of over 12 million people (PMID 34817582) found that long-term Alpha-GPC users had a higher 10-year risk of new stroke (adjusted hazard ratio 1.43, with ischemic and hemorrhagic events both raised) in a dose-dependent pattern. Recovering from a stroke and developing a new one are different endpoints, but for anyone with cerebrovascular disease this signal turns a shaky benefit into a serious reason for caution rather than reassurance.
No authority endorses Alpha-GPC for stroke recovery. The US FDA only states it 'has no questions' about its use as a food-grade choline source, which is a safety (GRAS) notice and not a treatment endorsement; EFSA, the NHS and WHO did not address the question at all. Likewise, no major clinical body, including NIH ODS, Mayo Clinic, Cleveland Clinic and Harvard Health, recommends it for stroke patients. Established multidisciplinary rehabilitation remains the standard of care.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.485
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status